Director Global Strategic Planning - Digital Transformation, Sandoz International

Location: Holzkirchen, Germany
Job Type: Full-Time
Employer: Sandoz (Novartis Group)
Sandoz is currently recruiting for a Director Global Strategic Planning - Digital Transformation to join our Global Strategic Team to lead large-scale, global strategic initiatives to drive significant business improvement in digital area.

The purpose of the Director Global Strategic Planning role is to Manage multiple, cross-functional project teams ensuring rapid results generation of assigned initiatives.

Key Responsibilities

  • Set the digital aspiration for Sandoz and translate that into a tangible roadmap for the next 3-5 years and beyond
  • Closely collaborate with all Novartis divisions to identify synergies and opportunities along digital agenda and solutions
  • Drive the implementation across functions and geographies in Sandoz and track the success
  • Work with key stakeholders in top management to enable their “digital readiness” and informed decision making
  • Build and coordinate a small capable team to develop solutions on how we innovate, sell and operate
  • Act as the crystallization point for all digital topics of strategic value between Sandoz and external world, i.e.,
  • Respond to or identify business challenges within Sandoz which could be resolved by digital solutions and coordinate the solution
  • Identify new business models in the market (products and services) that may be a model for Sandoz and push their adoption in the division
  • Actively identify and start collaborations with external parties (e.g., startups) which can also be exploratory in nature
  • Help initiatives and colleagues (individually or in groups) to become more digital, more agile and more customer-centric

Minimum requirements

  • Significant experience at top tier consultancy (with relevant CXO interaction)
  • Proven experience as project manager is a must-have, ideally
  • First-hand experience in developing and delivering digital strategies/transformations along e.g,. multi-channel, web-enabled design, big data analytics, cloud computing, e-commerce etc.
  • Highly desired: Demonstrable track-record in building digital businesses, particularly as a founder
  • Savviness in innovative digital trends, e.g. IoT, Blockchain, Artificial Intelligence, Neural Networks etc
  • Top academic achievements
  • Fluency in English & at least 1 additional European language
  • Tested capability to successfully lead teams and projects, often with tight time constraints
  • Entrepreneurial spirit with Can-do, pro-active attitude
  • Excellent communication and presentation skills

Apply for this job

About Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2016 sales of USD 10.1 billion. In 2016, our products reached well over 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.

Sandoz Biopharmaceuticals, a global business unit of Sandoz, comprises biosimilars, contract manufacturing and Glatopa 20mg (glatiramer acetate). It is a USD one billion business (2016 annual sales). As the pioneer and global leader in biosimilars, with sales in 86 countries and five marketed biosimilars in Europe, Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars. Its biosimilar products (Omnitrope, Binocrit, Zarzio/Zarzio, Rixathon and Erelzi) have generated more than 340 million patient days of experience. Sandoz has a leading biosimilar pipeline and plans to launch a total of five biosimilars of major oncology and immunology biologics across major markets between 2017 and 2020. A division of the Novartis Group, Sandoz is well-positioned to continue leading the biosimilars industry based on its experience and capabilities in development, manufacturing, and commercialization.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Generative AI can Not yet Reliably Read …

It may someday be possible to use Large Language Models (LLM) to automatically read clinical notes in medical records and reliably and efficiently extract relevant information to support patient care...

AI can Help Rule out Abnormal Pathology …

A commercial artificial intelligence (AI) tool used off-label was effective at excluding pathology and had equal or lower rates of critical misses on chest X-ray than radiologists, according to a...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

What Does the EU's Recent AI Act Me…

The European Union's law on artificial intelligence came into force on 1 August. The new AI Act essentially regulates what artificial intelligence can and cannot do in the EU. A...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...